Company intelligence / Profile preview

EDC Biosystems

Milpitas, California, USA

Ownership: Private
Employees: ~25
Development stage: Other

Overview

EDC Biosystems was a life science instrumentation company specializing in high-precision acoustic liquid handling technology. The company's flagship product, the ATS-100 Acoustic Transfer System, enabled the touchless transfer of nanoliter-scale fluid volumes using ultrasonic energy, minimizing cross-contamination and reagent waste. This technology was primarily utilized in high-throughput screening, genomics, and drug discovery applications to improve assay accuracy and reduce costs. In 2016, the company was acquired by Labcyte, which was subsequently integrated into Beckman Coulter Life Sciences, a Danaher company.

Modalities: Device
Industry: Drug Discovery Services

Beyond the preview

Go deeper on EDC Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EDC Biosystems.

Explore the full profile